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Abstract
Salt sensitivity and insulin resistance are correlated with higher cardiovascular risk. There is no information about changes in 
salt sensitivity (SS) and insulin sensitivity (IS) after a chronic salt overload in humans. The aim of this study was to evaluate 
these parameters in the elderly. Seventeen volunteers aged 70.5 ± 5.9 years followed a low-salt diet (LSD) for 1 week and 
a high-salt diet (HSD) for 13 weeks. We evaluated SS after one week (HSD1) and after 13 weeks (HSD13), and subjects’ IS 
and lipids on their usual diet (UD) at HSD1, and at HSD13. Blood pressure (BP) was measured at each visit and ambulatory 
blood pressure monitoring (ABPM) was performed twice. SS was the same at HSD1 and HSD13. Systolic BP was lower on 
LSD than on UD (P = 0.01), HSD1 (P < 0.01) and HSD13 (P < 0.01). When systolic and diastolic BP were evaluated by ABPM, 
they were higher at HSD13 during the 24-h period (P = 0.03 and P < 0.01) and during the wakefulness period (P = 0.02 and P 
< 0.01) compared to the UD. Total cholesterol was higher (P = 0.04) at HSD13 than at HSD1. Glucose and homeostasis model 
assessment (HOMA) were lower at HSD1 (P = 0.02 and P = 0.01) than at HSD13. Concluding, the extension of HSD did not 
change the SS in an elderly group. The higher IS found at HSD1 did not persist after a longer HSD. A chronic HSD increased 
BP as assessed by ABPM. 
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ranges from 9 (9) to 70 mEq (10) of sodium per day, and 
salt overload from 150 (11) to 345 mEq (10). There are also 
different classifications of salt sensitivity. Some investiga-
tors consider it necessary to have a mean BP increase 
of 5% (12), others of 10% (13) from LSD to HSD to clas-
sify someone as being salt sensitive. Other investigators 
prefer to consider absolute values, for example, a mean 
BP increase of 3 mmHg between diets (14). Finally, some 
investigators classify salt sensitivity in steps, ranging from 
the lowest to the highest (15). 
In addition to all of these differences among protocols, 
one important question remains unanswered: is one week of 
salt overload sufficient to evaluate the salt effect? If a longer 
period of salt overload was provided, would the individual’s 
classification or the test result be changed?
Salt intake is clearly associated with high blood pressure 
(BP) in epidemiologic studies (1,2). However, individuals 
are not homogeneous in their BP response to high salt 
intake. Salt overload increases (salt-sensitive individuals), 
maintains or sometimes even decreases BP (salt-resistant 
individuals) (3). It is known that salt sensitivity is correlated 
with higher cardiovascular risk (4,5) and that it is more 
prevalent with increasing age (6,7). 
The most acceptable test to evaluate salt sensitivity is 
the oral test, in which the subject is submitted to a short 
period, usually of 1 week, of a low-salt diet (LSD) followed 
by the same period on a high-salt diet (HSD). Blood pressure 
is measured on the 7th day of each period (8). However, 
there are many differences among protocols regarding the 
intensity of salt restriction and salt overload. Salt restriction 
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HSD can change the metabolic status of animals and 
humans. Some previous studies have shown increased 
insulin sensitivity when salt overload is performed. Chronic 
HSD has been associated with higher insulin sensitivity in 
young (16,17) and old Wistar rats (18). One week of salt 
overload in healthy humans was also associated with higher 
insulin sensitivity when compared to salt restriction (19). 
On the other hand, studies on animals and humans have 
found lower insulin sensitivity during the use of HSD (20,21). 
These conflicting results can be attributed to differences in 
protocols and to associated diseases.
To the best of our knowledge, no previous study has 
evaluated the metabolic effect of prolonged salt overload 
in elderly humans.
Therefore, the aims of this study were to compare salt 
sensitivity measured after 1 week (the standard method) 
and after a prolonged salt overload in elderly people, and 
to evaluate the insulin sensitivity and lipid levels of these 
subjects on their usual diet and after 1 and 13 weeks of 
salt overload.
Subjects and Methods
The study was performed in accordance with the Dec-
laration of Helsinki (1989) and was approved by the Ethics 
Committee of the Hospital das Clínicas, Faculdade de Me-
dicina de Ribeirão Preto, Universidade de São Paulo, Brazil. 
Written informed consent was obtained from all subjects. 
Twenty elderly individuals (60 years or older) with no previ-
ous use of anti-hypertensive or anti-diabetic drugs, selected 
from the Geriatric Service of the Hospital das Clínicas, 
Faculdade de Medicina de Ribeirão Preto, Universidade 
de São Paulo, Brazil, were evaluated. Exclusion criteria 
were: mean blood pressure higher than 160 (systolic) and 
100 mmHg (diastolic), evidence of secondary hypertension, 
the diagnosis of cancer or other states of disability, use 
of drugs that potentially increase BP (non-steroidal and 
steroidal anti-inflammatory drugs, tricyclic antidepressants, 
vasoconstrictor drugs, etc.) and intake of more than 105 g 
of alcohol per week. Other medications in regular use were 
maintained until the end of the study. During the protocol, 
3 patients dropped out of the study because of epigastric 
pain with the intake of the salt capsules. The symptoms 
stopped immediately after interruption. Seventeen patients 
concluded the protocol. The volunteers were aged 70.5 ± 5.9 
years, 10 women, white, 4 with untreated hypertension (3 
of them with white coat hypertension), 10 with high-normal 
BP and 3 normotensives.
Mean basal BP was obtained with an automatic device 
(Dixtal 2710, Brazil) in the Clinician’s office. Three measure-
ments were obtained at the first visit (Visit 1) and three after 
1 week (Visit 2). The diagnosis of hypertension (systolic BP 
of 140 mmHg or higher and/or diastolic BP of 90 mmHg or 
higher) and high-normal BP (systolic BP of 120 mmHg or 
higher and/or diastolic BP of 80 mmHg or higher) was made 
on the basis of the mean of these six measurements with the 
subjects on their usual diet. Body weight  was measured at 
the first visit. A blood sample was drawn for the determina-
tion of fasting blood glucose (Glicose HK Liquiform, Labtest, 
Brazil), HDL-cholesterol (HDL Cholesterol monophase AA 
plus, Wiener Lab., Argentina), total cholesterol (Colestat, 
Wiener Lab.), triglycerides (TG Color GPO/PAP AA, Wiener 
Lab.), and serum insulin (Coat-A-Count Insulin, Siemens, 
USA). Three 24-h urine specimens were collected for the 
determination of urinary sodium excretion (UNaV). Twenty-
four-hour ambulatory blood pressure monitoring (ABPM) 
was performed on the non-dominant limb (Spacelabs-90207, 
USA) (22). The device was programmed to take measure-
ments every 15 min from 7:00 am to 11:00 pm (awake 
period), and every 20 min from 11:00 pm to 7:00 am (asleep 
period). Recordings were accepted only if at least 80% of 
the readings could be successfully obtained. Data from the 
monitors were downloaded into a computer and rejected 
if systolic BP was lower than 80 mmHg or higher than 250 
mmHg and if diastolic BP was lower than 40 mmHg or 
higher than 140 mmHg.
After Visit 2, LSD was started. Patients were instructed 
to use no salt for cooking and to add no salt to cooked or 
raw food. They were also asked to avoid industrialized food. 
During this period, volunteers received capsules of placebo 
to be taken three times a day, two capsules at each time, 
after breakfast, lunch and dinner. A 24-h urine specimen 
was collected on the 7th day and volunteers returned to 
the office to have their BP measured (six measurements 
at each visit, from Visit 3) and to be weighed. A volunteer 
was considered to have followed the LSD when the UNaV 
dropped at least 100 mmol from usual diet UNaV or became 
lower than 100 mmol/day. Fifteen volunteers reached that 
goal and only their results were considered to evaluate salt 
sensitivity at this point in the study. At that time, the volun-
teers were asked to continue preparing the diet as before 
but now with 6 g of salt added per day (two packages of 3 
g each) and to take 6 capsules of 1 g of salt each following 
the same regimen employed with the placebo (total increase 
of 200 mmol sodium/day).
One week later, 24-h urine was collected, a second 
blood sample was drawn (biochemistry was repeated), and 
BP and body weight were determined (Visit 4).
High salt intake was maintained until the end of the 
study. Twenty-four-hour urine was collected every 14 days 
in order to confirm the maintenance of the high salt intake 
(Visits 5 to 10). At each visit the number of salt and placebo 
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capsules was counted so that the researcher could also 
check compliance by counting the capsules. At the last 
visit, after 13 weeks of salt overload, a second ABPM was 
performed, body weight was measured and a third blood 
sample was drawn for biochemical tests. 
If systolic BP increased at least 10 mmHg from LSD to 
HSD, patients were considered to be salt sensitive.
The homeostasis model assessment (HOMA) was deter-
mined by the following formula: insulin resistance = plasma 
insulin (pmol/L) x blood glucose (mmol/L) / 135 (23). 
Statistical analysis
The results obtained with the patients on their usual diet, 
LSD, after 1 week of HSD (HSD1), and after 13 weeks of 
HSD (HSD13) were compared with a unified approach to 
mixed linear models (24,25) (SAS/STAT®, Version 9, USA: 
SAS Institute Inc., 2002-2003). The mean BPs obtained by 
ABPM during the basal period and after 13 weeks of HSD 
were compared by the Student paired test. The McNemar 
test was used to compare salt sensitivity after 1 week and 
after 13 weeks of salt overload (26). Results are reported 
as means ± SD.
Results
The usual UNaV was 215.24 ± 133.08 mmol/day (N = 
17). After 1 week of LSD, UNaV was 70.03 ± 57.97 mmol/
day (N = 15; P < 0.01, LSD vs usual, HSD1 and HSD13). 
After 1 week of salt overload, UNaV was 297.75 ± 112.75 
mmol/day (N = 17; P = 0.01 vs usual), and these levels were 
maintained up to the 13th week (294.71 ± 104.83 mmol/
day, N = 17; P = 0.01 vs usual).
Ten of 15 subjects were classified as salt sensitive after 
1 week and 13 weeks of salt overload. Three volunteers 
classified as salt resistant after 1 week of salt overload 
were classified as salt sensitive after 13 weeks and three 
volunteers initially classified as salt sensitive were classified 
as salt resistant after 13 weeks. The group salt sensitivity 
was the same after one or 13 weeks of salt overload (P 
> 0.05).
Systolic BP was lower on LSD than on the usual diet 
(P = 0.01), HSD1 (P < 0.01) and HSD13 (P < 0.01; Figure 
1A). There was no difference (P = 0.13) between usual diet 
systolic BP and HSD13 BP. However, when systolic BP 
was evaluated by ABPM, it was higher after 13 weeks of 
salt overload during the 24-h period (P = 0.03) and during 
the awake period only (P = 0.02) compared with the usual 
diet  (Table 1).
Diastolic BP was lower on LSD than on the usual diet 
(P = 0.03) and HSD13 (P = 0.01; Figure 1B). There was 
no difference (P = 0.51) between usual diet diastolic BP 
and HSD13, though diastolic BP assessed by ABPM was 
higher during the 24-h period (P < 0.01) and during the 
awake period (P < 0.01) after chronic overload than on the 
usual diet (Table 1).
Body weight did not differ among usual diet (66 ± 15 
Figure 1. Systolic (A) and diastolic (B) blood pressures of sub-
jects on different salt diets. Box plots indicating the median (thick 
line), the mean (filled lozenges), and range of blood pressure of 
subjects on their usual diet (215.24 ± 133.08 mmol sodium/day), 
on a low-salt diet (LSD, 70.03 ± 57.97 mmol sodium/day), and 
after 1 week (HSD1, 297.75 ± 112.75 mmol sodium/day) and 13 
weeks (HSD13, 294.71 ± 104.83 mmol sodium/day) on a high-
salt diet. The boundaries of the box indicate the lower and upper 
quartiles. Open lozenges: Outliers with values between 1.5 and 
3 box lengths from the boundaries of the box. A: *P = 0.01 vs 
usual, and P < 0.01 vs HSD1 and HSD13 (mixed linear model 
test). B: *P = 0.03 vs usual, and P = 0.01 vs HSD13 (mixed linear 
model test).
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kg), LSD (65 ± 17 kg), HSD1 (67 ± 17 kg), and HSD13 (67 
± 15 kg; P > 0.05).
Total cholesterol was higher (P = 0.04) at HSD13 than 
at HSD1. HDL-cholesterol and triglycerides were similar 
on all diets (Table 2).
Glucose and HOMA were lower (P = 0.02 and P = 0.01, 
respectively) at HSD1 than at HSD13 (Table 2). There was 
no difference in insulin sensitivity (P = 0.3) between usual 
diet and HSD13. 
Discussion 
It is known that changes in salt intake can modify BP 
in animals (18,27) and humans (28). Recently, Elliott et 
al. (29) reported a three-year study with chimpanzees in 
which BP fell significantly after a sodium intake reduction of 
100 mmol/day. Kojuri and Rahimi (30) showed that even a 
modest reduction of sodium intake (37 mmol/day) reduced 
the ABPM of untreated hypertensive patients. The present 
study also found lower Clinician’s office BP in volunteers 
on LSD than on their usual or high-salt diet. Using ABPM, 
which has prognostic superiority over conventional BP 
measurements (31), higher 24-h BP and BP during the 
wakefulness period were detected after a long period of 
high salt intake compared with the usual diet. The mean 
difference between urinary sodium on the usual diet and 
after 13 weeks on HSD was about 80 mmol per day. To the 
best of our knowledge, this is the first time that a prolonged 
HSD was administered to humans. 
Because the study population was elderly, we decided 
to employ systolic BP to evaluate salt sensitivity, since 
mean BP, more frequently used in salt-sensitivity studies, is 
influenced by the lower diastolic BP in elderly patients, as-
sociated with their increased arterial stiffness (32). Patients 
had substantial salt sensitivity, with a mean increase of 14 ± 
7 mmHg from LSD to HSD1, similar to the results reported 
by Sowers et al. (33) who reported a systolic BP increase 
of 12 ± 0.3 mmHg in African-American patients.
In order to evaluate salt sensitivity it would be ideal to 
have achieved a lower salt consumption during the LSD 
week, since some individuals had mean urinary sodium 
excretion of about 100 mmol/day, which could be considered 
as a normal salt diet. On the other hand, there was a great 
difference between salt consumption during the LSD and 
the HSD in this study. 
The analysis of a longer period of HSD intake did not 
affect the overall result of the salt-sensitivity test, although, 
individually, a few cases would be classified differently after 
a longer period on the HSD.
The HOMA method was chosen to evaluate insulin 
sensitivity in this study because it is simple, easily applied, 
and has good reproducibility (34). The HOMA estimate of 
insulin sensitivity significantly correlates with data derived 
from forearm metabolic studies involving direct measure-
ments of insulin action on muscle glucose metabolism (35). 
The finding of higher insulin sensitivity after 1 week of HSD 
than after 13 weeks, with no changes in body weight, ap-
pears to indicate that the positive effect of salt on insulin 
sensitivity is transitory, at least in the elderly volunteers 
studied. After 13 weeks of salt overload, insulin sensitivity 
was the same as that determined at the beginning of the 
study, when the subjects were on their usual diet. Prob-
ably, different species have distinct characteristics, since 
Okamoto et al. (36), studying Wistar rats after 9 weeks of 
Table 2. Comparison of metabolic factors for subjects on differ-
ent diets.
Usual diet High-salt diet 
for 1 week
High-salt diet 
for 13 weeks 
T-Chol (mmol/L) 5.4 ± 0.8 5.3 ± 1.0 5.6 ± 0.8*
HDL (mmol/L) 1.5 ± 0.4 1.4 ± 0.4 1.5 ± 0.4
Triglycerides (mmol/L) 1.3 ± 0.6 1.3 ± 0.6 1.4 ± 0.6
Glucose (mmol/L) 5.4 ± 0.8 5.1 ± 0.4 5.6 ± 0.9*
Insulin (pmol/L) 69.5 ± 41.7 55.6 ± 34.7 62.5 ± 34.7
HOMA (pmol/L·mmol/L) 2.72 ± 1.73 1.87 ± 1.27 3.06 ± 1.89*
Data are reported as means ± SD for N = 17 subjects. T-Chol 
= total cholesterol; HDL = high-density lipoprotein; HOMA = ho-
meostasis model assessment. Usual diet: 215.24 ± 133.08 mmol 
sodium/day; high-salt diet: 297.75 ± 112.75 mmol sodium/day 
(after 1 week) and 294.71 ± 104.83 mmol sodium/day (after 13 
weeks). *P < 0.05 compared to high-salt diet for 1 week (mixed 
linear models).
Table 1. Ambulatory 24-h blood pressure monitoring during the 
awake and asleep periods of elderly subjects on their usual diet 
and after a long-term (13 weeks) high-salt diet. 
Period Usual diet High-salt diet 
24-h
Systolic 120 ± 12 127 ± 11*
Diastolic 70 ± 8 74 ± 7*
Awake
Systolic 121 ± 13 128 ± 11*
Diastolic 71 ± 8 75 ± 7*
Asleep
Systolic 116 ± 12 123 ± 12
Diastolic 65 ± 10 70 ± 9
Data are reported as means ± SD for N = 17 subjects. Usual 
diet: 215.24 ± 133.08 mmol sodium/day; high-salt diet: 294.71 ± 
104.83 mmol sodium/day. Blood pressure was measured by 24-h 
ambulatory blood pressure monitoring. *P < 0.05 compared to 
usual diet (Student paired test).
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a normal-salt diet (0.5% sodium), of LSD (0.06% sodium) 
or HSD (3.12% sodium), found that insulin sensitivity was 
higher in rats on HSD than on a normal-salt diet, with higher 
insulin-regulated glucose transporter (GLUT4) expression, 
enhanced insulin signaling, and GLUT4 translocation. 
Severe salt restriction (20 to 60 mmol sodium/day) has 
been associated with higher cholesterol levels (37,38); 
however, moderate salt restriction of 85 mmol sodium/
day does not modify lipid concentration (37). The present 
study showed a modest increase of cholesterol levels after 
prolonged high salt intake. A salt-rich diet for 4 or 5 weeks 
also increased cholesterol levels in lean and obese Zucker 
rats (39) but the mechanism responsible for this effect has 
not been elucidated. 
As the extension of salt overload period after one week 
of low-salt diet did not change the salt sensitivity in this 
group, we can determine it using the traditional shorter 
method. Since there was no higher insulin sensitivity after 
a prolonged salt overload, which was previously shown in 
animal models, and higher BP and cholesterol levels were 
detected, the results point to a potential harmful effect of 
an increase in sodium intake, even though the usual diet 
already had a high salt content. The findings of the pres-
ent study may not be applicable to young or middle-aged 
individuals, since these groups were not submitted to pro-
longed high-salt diet before and the numerous differences 
between groups, with higher salt sensitivity and lower insulin 
sensitivity being characteristic of the elderly.
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